Science (1992) 255(5042):30612.10.1126/science.1549776 4 BaumgartnerJWWellsCAChenCMWatersMJ
In this study, participants using semaglutide had a lower risk for CVD-related events when compared with placebo.38 These results build on prior evidence that GLP-1s not only support blood sugar and weight management but also offer significant cardiovascular protection in high-risk populations.39 A 2021 systematic review published in Diabetes & Metabolic Syndrome: Clinical Research & Reviews examined six studies involving over 182,000 adults with T2DM to evaluate the cardioprotective effects of GLP-1s (primarily liraglutide and exenatide) taken in conjunction with blood pressure and cholesterol lowering medications.40 The findings showed consistent improvements in cardiac function, including increased left ventricular ejection fraction40 and reduced heart chamber volume, along with weight loss and improved myocardial blood flow

To make sure you arent missing a mild vitamin B12 deficiency, you can also proactively check for low vitamin B12 levels if you or your older relative is suffering from any of the common risk factors associated with this condition
No Insurance Needed: Transparent pricing with no hidden or additional costs
Over time, this causes the body to use stored fat for fuel, leading to weight loss
In some cases, Ro requires initial lab testing before starting treatment